Necroptosis: A new way of dying?

Cancer Biology and Therapy

Volumn 17, Issue 9, 2016, Pages 899-910

  Hanson, Britt ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Apoptosis; cancer; ferroptosis; necroptosis; necrosis; pyroptosis

Indexed keywords

CASPASE; INTERFERON; IRON; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; CANCER THERAPY; CELL DEATH; CHIMERA; DNA DAMAGE; FERROPTOSIS; HUMAN; NECROPTOSIS; NONHUMAN; PYROPTOSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; NECROSIS; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; NECROSIS;

EID: 84983504430     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2016.1210732     Document Type: Review

References (120)

1. J.F.Kerr, A.H.Wyllie, A.R.Currie. Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57; PMID:4561027; http://dx.doi.org/10.1038/bjc.1972.33
2. K.Hardy, A.H.Handyside, R.M.Winston. The human blastocyst:cell number, death and allocation during late preimplantation development in vitro. Development 1989; 107:597-604; PMID:2612378
3. L.Galluzzi, I.Vitale, J.M.Abrams, E.S.Alnemri, E.H.Baehrecke, M.V.Blagosklonny, T.M.Dawson, V.L.Dawson, W.S.El-Deiry, S.Fulda, et al. Molecular definitions of cell death subroutines:recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107-20; PMID:21760595; http://dx.doi.org/10.1038/cdd.2011.96
4. L.Galluzzi, J.M.Bravo-San Pedro, I.Vitale, S.A.Aaronson, J.M.Abrams, D.Adam, E.S.Alnemri, L.Altucci, D.Andrews, M.Annicchiarico-Petruzzelli, et al. Essential versus accessory aspects of cell death:recommendations of the NCCD 2015. Cell Death Differ 2015; 22:58-73; PMID:25236395; http://dx.doi.org/10.1038/cdd.2014.137
5. R.A.Lockshin, C.M.Williams. Programmed Cell Death -II. Endocrine Potentiation of the Breakdown of the Intersegmental Muscles of Silkmoths. J Ins Physiol 1964; 10:643-9; http://dx.doi.org/10.1016/0022-1910(64)90034-4
6. A.Kaczmarek, P.Vandenabeele, D.V.Krysko. Necroptosis:the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38:209-23; PMID:23438821; http://dx.doi.org/10.1016/j.immuni.2013.02.003
7. M.Dannappel, K.Vlantis, S.Kumari, A.Polykratis, C.Kim, L.Wachsmuth, C.Eftychi, J.Lin, T.Corona, N.Hermance, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 2014; 513:90-4; PMID:25132550; http://dx.doi.org/10.1038/nature13608
8. P.Bouillet, L.A.O'Reilly. CD95, BIM and T cell homeostasis. Nat Rev Immunol 2009; 9:514-9; PMID:19543226; http://dx.doi.org/10.1038/nri2570
9. W.P.Roos, B.Kaina. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12:440-50; PMID:16899408; http://dx.doi.org/10.1016/j.molmed.2006.07.007
10. C.V.Nogueira, T.Lindsten, A.M.Jamieson, C.L.Case, S.Shin, C.B.Thompson, C.R.Roy. Rapid pathogen-induced apoptosis:a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila. PLoS pathogens 2009; 5:e1000478; PMID:19521510; http://dx.doi.org/10.1371/journal.ppat.1000478
11. H.B.Shu, M.Takeuchi, D.V.Goeddel. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci U S A 1996; 93:13973-8; PMID:8943045; http://dx.doi.org/10.1073/pnas.93.24.13973
12. O.Micheau, J.Tschopp. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes. Cell 2003; 114:181-90; PMID:12887920; http://dx.doi.org/10.1016/S0092-8674(03)00521-X
13. O.Micheau, S.Lens, O.Gaide, K.Alevizopoulos, J.Tschopp. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21:5299-305; PMID:11463813; http://dx.doi.org/10.1128/MCB.21.16.5299-5305.2001
14. N.Holler, R.Zaru, O.Micheau, M.Thome, A.Attinger, S.Valitutti, J.L.Bodmer, P.Schneider, B.Seed, J.Tschopp. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1:489-95; PMID:11101870; http://dx.doi.org/10.1038/82732
15. F.C.Kischkel, S.Hellbardt, I.Behrmann, M.Germer, M.Pawlita, P.H.Krammer, M.E.Peter. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14:5579-88; PMID:8521815
16. I.N.Lavrik, P.H.Krammer. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 2012; 19:36-41; PMID:22075988; http://dx.doi.org/10.1038/cdd.2011.155
17. D.E.Christofferson, Y.Li, J.Hitomi, W.Zhou, C.Upperman, H.Zhu, S.A.Gerber, S.Gygi, J.Yuan. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis 2012; 3:e320; PMID:22695613; http://dx.doi.org/10.1038/cddis.2012.64
18. N.Harper, M.Hughes, M.MacFarlane, G.M.Cohen. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 2003; 278:25534-41; PMID:12721308; http://dx.doi.org/10.1074/jbc.M303399200
19. M.J.Bertrand, S.Milutinovic, K.M.Dickson, W.C.Ho, A.Boudreault, J.Durkin, J.W.Gillard, J.B.Jaquith, S.J.Morris, P.A.Barker. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008; 30:689-700; PMID:18570872; http://dx.doi.org/10.1016/j.molcel.2008.05.014
20. E.Varfolomeev, T.Goncharov, A.V.Fedorova, J.N.Dynek, K.Zobel, K.Deshayes, W.J.Fairbrother, D.Vucic. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283:24295-9; PMID:18621737; http://dx.doi.org/10.1074/jbc.C800128200
21. F.K.Chan, J.Shisler, J.G.Bixby, M.Felices, L.Zheng, M.Appel, J.Orenstein, B.Moss, M.J.Lenardo. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 2003; 278:51613-21; PMID:14532286; http://dx.doi.org/10.1074/jbc.M305633200
22. S.L.Petersen, T.T.Chen, D.A.Lawrence, S.A.Marsters, F.Gonzalvez, A.Ashkenazi. TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ 2015; 22(11):1846-57; PMID:25882049; http://dx.doi.org/10.1038/cdd.2015.35
23. A.K.Muller-Rischart, A.Pilsl, P.Beaudette, M.Patra, K.Hadian, M.Funke, R.Peis, A.Deinlein, C.Schweimer, P.H.Kuhn, et al. The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell 2013; 49:908-21; PMID:23453807; http://dx.doi.org/10.1016/j.molcel.2013.01.036
24. K.Verhelst, I.Carpentier, M.Kreike, L.Meloni, L.Verstrepen, T.Kensche, I.Dikic, R.Beyaert. A20 inhibits LUBAC-mediated NF-kappaB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J 2012; 31:3845-55; PMID:23032186; http://dx.doi.org/10.1038/emboj.2012.240
25. A.Oberst, C.P.Dillon, R.Weinlich, L.L.McCormick, P.Fitzgerald, C.Pop, R.Hakem, G.S.Salvesen, D.R.Green. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011; 471:363-7; PMID:21368763; http://dx.doi.org/10.1038/nature09852
26. C.Pop, A.Oberst, M.Drag, B.J.Van Raam, S.J.Riedl, D.R.Green, G.S.Salvesen. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 2011; 433:447-57; PMID:21235526; http://dx.doi.org/10.1042/BJ20101738
27. H.E.Kim, F.Du, M.Fang, X.Wang. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci U S A 2005; 102:17545-50; PMID:16251271; http://dx.doi.org/10.1073/pnas.0507900102
28. E.Ottina, M.Sochalska, R.Sgonc, A.Villunger. The BH3-only protein Bad is dispensable for TNF-mediated cell death. Cell Death Dis 2015; 6:e1611; PMID:25611386; http://dx.doi.org/10.1038/cddis.2014.575
29. L.Cabon, P.Galan-Malo, A.Bouharrour, L.Delavallee, M.N.Brunelle-Navas, H.K.Lorenzo, A.Gross, S.A.Susin. BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. Cell Death Differ 2012; 19:245-56; PMID:21738214; http://dx.doi.org/10.1038/cdd.2011.91
30. C.Du, M.Fang, Y.Li, L.Li, X.Wang. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102:33-42; PMID:10929711; http://dx.doi.org/10.1016/S0092-8674(00)00008-8
31. J.E.Vince, W.W.Wong, N.Khan, R.Feltham, D.Chau, A.U.Ahmed, C.A.Benetatos, S.K.Chunduru, S.M.Condon, M.McKinlay, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131:682-93; PMID:18022363; http://dx.doi.org/10.1016/j.cell.2007.10.037
32. E.Varfolomeev, J.W.Blankenship, S.M.Wayson, A.V.Fedorova, N.Kayagaki, P.Garg, K.Zobel, J.N.Dynek, L.O.Elliott, H.J.Wallweber, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131:669-81; PMID:18022362; http://dx.doi.org/10.1016/j.cell.2007.10.030
33. M.L.Wurstle, M.Rehm. A systems biology analysis of apoptosome formation and apoptosis execution supports allosteric procaspase-9 activation. J Biol Chem 2014; 289:26277-89; PMID:25107908; http://dx.doi.org/10.1074/jbc.M114.590034
34. T.T.Vo, J.Ryan, R.Carrasco, D.Neuberg, D.J.Rossi, R.M.Stone, D.J.Deangelo, M.G.Frattini, A.Letai. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 2012; 151:344-55; PMID:23063124; http://dx.doi.org/10.1016/j.cell.2012.08.038
35. N.Festjens, T.Vanden Berghe, P.Vandenabeele. Necrosis, a well-orchestrated form of cell demise:signalling cascades, important mediators and concomitant immune response. Biochimica et biophysica acta 2006; 1757:1371-87; PMID:16950166; http://dx.doi.org/10.1016/j.bbabio.2006.06.014
36. A.Degterev, Z.Huang, M.Boyce, Y.Li, P.Jagtap, N.Mizushima, G.D.Cuny, T.J.Mitchison, M.A.Moskowitz, J.Yuan. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1:112-9; PMID:16408008; http://dx.doi.org/10.1038/nchembio711
37. T.Hirsch, P.Marchetti, S.A.Susin, B.Dallaporta, N.Zamzami, I.Marzo, M.Geuskens, G.Kroemer. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15:1573-81; PMID:9380409; http://dx.doi.org/10.1038/sj.onc.1201324
38. P.J.Sansonetti, A.Phalipon, J.Arondel, K.Thirumalai, S.Banerjee, S.Akira, K.Takeda, A.Zychlinsky. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 2000; 12:581-90; PMID:10843390; http://dx.doi.org/10.1016/S1074-7613(00)80209-5
39. G.Doitsh, N.L.Galloway, X.Geng, Z.Yang, K.M.Monroe, O.Zepeda, P.W.Hunt, H.Hatano, S.Sowinski, I.Munoz-Arias, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505:509-14; PMID:24356306; http://dx.doi.org/10.1038/nature12940
40. S.Mariathasan, K.Newton, D.M.Monack, D.Vucic, D.M.French, W.P.Lee, M.Roose-Girma, S.Erickson, V.M.Dixit. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430:213-8; PMID:15190255; http://dx.doi.org/10.1038/nature02664
41. F.Martinon, K.Burns, J.Tschopp. The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:417-26; PMID:12191486; http://dx.doi.org/10.1016/S1097-2765(02)00599-3
42. J.Shi, Y.Zhao, K.Wang, X.Shi, Y.Wang, H.Huang, Y.Zhuang, T.Cai, F.Wang, F.Shao. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526:660-5; PMID:26375003; http://dx.doi.org/10.1038/nature15514
43. N.Kayagaki, I.B.Stowe, B.L.Lee, K.O'Rourke, K.Anderson, S.Warming, T.Cuellar, B.Haley, M.Roose-Girma, Q.T.Phung, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015; 526:666-71; PMID:26375259; http://dx.doi.org/10.1038/nature15541
44. N.Saeki, T.Usui, K.Aoyagi, D.H.Kim, M.Sato, T.Mabuchi, K.Yanagihara, K.Ogawa, H.Sakamoto, T.Yoshida, et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer 2009; 48:261-71; PMID:19051310; http://dx.doi.org/10.1002/gcc.20636
45. V.Derangere, A.Chevriaux, F.Courtaut, M.Bruchard, H.Berger, F.Chalmin, S.Z.Causse, E.Limagne, F.Vegran, S.Ladoire, et al. Liver X receptor beta activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ 2014; 21:1914-24; PMID:25124554; http://dx.doi.org/10.1038/cdd.2014.117
46. C.V.Miller, I.S.Cook, R.Jayaramachandran, A.G.Tyers. Spontaneous regression of a conjunctival malignant melanoma. Orbit 2014; 33:139-41; PMID:24295209; http://dx.doi.org/10.3109/01676830.2013.851708
47. S.J.Dixon, K.M.Lemberg, M.R.Lamprecht, R.Skouta, E.M.Zaitsev, C.E.Gleason, D.N.Patel, A.J.Bauer, A.M.Cantley, W.S.Yang, et al. Ferroptosis:an iron-dependent form of nonapoptotic cell death. Cell 2012; 149:1060-72; PMID:22632970; http://dx.doi.org/10.1016/j.cell.2012.03.042
48. Y.Xie, W.Hou, X.Song, Y.Yu, J.Huang, X.Sun, R.Kang, D.Tang. Ferroptosis:process and function. Cell Death Differ 2016; 23:369-79; PMID:26794443; http://dx.doi.org/10.1038/cdd.2015.158
49. N.Yagoda, M.von Rechenberg, E.Zaganjor, A.J.Bauer, W.S.Yang, D.J.Fridman, A.J.Wolpaw, I.Smukste, J.M.Peltier, J.J.Boniface, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007; 447:864-8; PMID:17568748; http://dx.doi.org/10.1038/nature05859
50. S.Torii, R.Shintoku, C.Kubota, M.Yaegashi, R.Torii, M.Sasaki, T.Suzuki, M.Mori, Y.Yoshimoto, T.Takeuchi, et al. An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem J 2016; 473:769-77; PMID:26759376; http://dx.doi.org/10.1042/BJ20150658
51. S.J.Dixon, B.R.Stockwell. The role of iron and reactive oxygen species in cell death. Nat Chem Biol 2014; 10:9-17; PMID:24346035; http://dx.doi.org/10.1038/nchembio.1416
52. N.Eling, L.Reuter, J.Hazin, A.Hamacher-Brady, N.R.Brady. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2015; 2:517-32; PMID:26097885; http://dx.doi.org/10.18632/oncoscience.160
53. H.Lai, T.Sasaki, N.P.Singh. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Expert Opin Ther Targets 2005; 9:995-1007; PMID:16185154; http://dx.doi.org/10.1517/14728222.9.5.995
54. E.Ooko, M.E.Saeed, O.Kadioglu, S.Sarvi, M.Colak, K.Elmasaoudi, R.Janah, H.J.Greten, T.Efferth. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine 2015; 22:1045-54; PMID:26407947; http://dx.doi.org/10.1016/j.phymed.2015.08.002
55. Y.S.Cho, S.Challa, D.Moquin, R.Genga, T.D.Ray, M.Guildford, F.K.Chan. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137:1112-23; PMID:19524513; http://dx.doi.org/10.1016/j.cell.2009.05.037
56. G.Trichonas, Y.Murakami, A.Thanos, Y.Morizane, M.Kayama, C.M.Debouck, T.Hisatomi, J.W.Miller, D.G.Vavvas. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci U S A 2010; 107:21695-700; PMID:21098270; http://dx.doi.org/10.1073/pnas.1009179107
57. J.M.Murphy, P.E.Czabotar, J.M.Hildebrand, I.S.Lucet, J.G.Zhang, S.Alvarez-Diaz, R.Lewis, N.Lalaoui, D.Metcalf, A.I.Webb, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39:443-53; PMID:24012422; http://dx.doi.org/10.1016/j.immuni.2013.06.018
58. E.A.Carswell, L.J.Old, R.L.Kassel, S.Green, N.Fiore, B.Williamson. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72:3666-70; PMID:1103152; http://dx.doi.org/10.1073/pnas.72.9.3666
59. D.W.Zhang, J.Shao, J.Lin, N.Zhang, B.J.Lu, S.C.Lin, M.Q.Dong, J.Han. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325:332-6; PMID:19498109; http://dx.doi.org/10.1126/science.1172308
60. S.He, L.Wang, L.Miao, T.Wang, F.Du, L.Zhao, X.Wang. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137:1100-11; PMID:19524512; http://dx.doi.org/10.1016/j.cell.2009.05.021
61. J.Hitomi, D.E.Christofferson, A.Ng, J.Yao, A.Degterev, R.J.Xavier, J.Yuan. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135:1311-23; PMID:19109899; http://dx.doi.org/10.1016/j.cell.2008.10.044
62. J.Li, T.McQuade, A.B.Siemer, J.Napetschnig, K.Moriwaki, Y.S.Hsiao, E.Damko, D.Moquin, T.Walz, A.McDermott, et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012; 150:339-50; PMID:22817896; http://dx.doi.org/10.1016/j.cell.2012.06.019
63. M.Feoktistova, P.Geserick, B.Kellert, D.P.Dimitrova, C.Langlais, M.Hupe, K.Cain, M.MacFarlane, G.Hacker, M.Leverkus. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43:449-63; PMID:21737330; http://dx.doi.org/10.1016/j.molcel.2011.06.011
64. T.Vanden Berghe, N.Vanlangenakker, E.Parthoens, W.Deckers, M.Devos, N.Festjens, C.J.Guerin, U.T.Brunk, W.Declercq, P.Vandenabeele. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010; 17:922-30; PMID:20010783; http://dx.doi.org/10.1038/cdd.2009.184
65. Z.Cai, S.Jitkaew, J.Zhao, H.C.Chiang, S.Choksi, J.Liu, Y.Ward, L.G.Wu, Z.G.Liu. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014; 16:55-65; PMID:24316671; http://dx.doi.org/10.1038/ncb2883
66. R.J.Thapa, S.Nogusa, P.Chen, J.L.Maki, A.Lerro, M.Andrake, G.F.Rall, A.Degterev, S.Balachandran. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 2013; 110:E3109-18; PMID:23898178; http://dx.doi.org/10.1073/pnas.1301218110
67. A.Hadji, P.Ceppi, A.E.Murmann, S.Brockway, A.Pattanayak, B.Bhinder, A.Hau, S.De Chant, V.Parimi, P.Kolesza, et al. Death induced by CD95 or CD95 ligand elimination. Cell Rep 2014; 7:208-22; PMID:24656822; http://dx.doi.org/10.1016/j.celrep.2014.02.035
68. S.McComb, E.Cessford, N.A.Alturki, J.Joseph, B.Shutinoski, J.B.Startek, A.M.Gamero, K.L.Mossman, S.Sad. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc Natl Acad Sci U S A 2014; 111:E3206-13; PMID:25049377; http://dx.doi.org/10.1073/pnas.1407068111
69. F.K.Chan, N.F.Luz, K.Moriwaki. Programmed necrosis in the cross talk of cell death and inflammation. Ann Rev Immunol 2015; 33:79-106; PMID:25493335; http://dx.doi.org/10.1146/annurev-immunol-032414-112248
70. J.M.Blander. A long-awaited merger of the pathways mediating host defence and programmed cell death. Nat Rev Immunol 2014; 14:601-18; PMID:25145756; http://dx.doi.org/10.1038/nri3720
71. M.Moulin, H.Anderton, A.K.Voss, T.Thomas, W.W.Wong, A.Bankovacki, R.Feltham, D.Chau, W.D.Cook, J.Silke, et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 2012; 31:1679-91; PMID:22327219; http://dx.doi.org/10.1038/emboj.2012.18
72. L.Duprez, N.Takahashi, F.Van Hauwermeiren, B.Vandendriessche, V.Goossens, T.Vanden Berghe, W.Declercq, C.Libert, A.Cauwels, P.Vandenabeele. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011; 35:908-18; PMID:22195746; http://dx.doi.org/10.1016/j.immuni.2011.09.020
73. H.Li, M.Kobayashi, M.Blonska, Y.You, X.Lin. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 2006; 281:13636-43; PMID:16543241; http://dx.doi.org/10.1074/jbc.M600620200
74. T.L.Haas, C.H.Emmerich, B.Gerlach, A.C.Schmukle, S.M.Cordier, E.Rieser, R.Feltham, J.Vince, U.Warnken, T.Wenger, et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 2009; 36:831-44; PMID:20005846; http://dx.doi.org/10.1016/j.molcel.2009.10.013
75. D.Brenner, H.Blaser, T.W.Mak. Regulation of tumour necrosis factor signalling:live or let die. Nat Rev Immunol 2015; 15:362-74; PMID:26008591; http://dx.doi.org/10.1038/nri3834
76. B.Gerlach, S.M.Cordier, A.C.Schmukle, C.H.Emmerich, E.Rieser, T.L.Haas, A.I.Webb, J.A.Rickard, H.Anderton, W.W.Wong, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011; 471:591-6; PMID:21455173; http://dx.doi.org/10.1038/nature09816
77. N.Vanlangenakker, M.J.Bertrand, P.Bogaert, P.Vandenabeele, T.Vanden Berghe. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2011; 2:e230; PMID:22089168; http://dx.doi.org/10.1038/cddis.2011.111
78. C.P.Dillon, A.Oberst, R.Weinlich, L.J.Janke, T.B.Kang, T.Ben-Moshe, T.W.Mak, D.Wallach, D.R.Green. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012; 1:401-7; PMID:22675671; http://dx.doi.org/10.1016/j.celrep.2012.03.010
79. S.Feng, Y.Yang, Y.Mei, L.Ma, D.E.Zhu, N.Hoti, M.Castanares, M.Wu. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007; 19:2056-67; PMID:17644308; http://dx.doi.org/10.1016/j.cellsig.2007.05.016
80. M.A.O'Donnell, E.Perez-Jimenez, A.Oberst, A.Ng, R.Massoumi, R.Xavier, D.R.Green, A.T.Ting. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011; 13:1437-42; PMID:22037414; http://dx.doi.org/10.1038/ncb2362
81. J.Seo, E.W.Lee, H.Sung, D.Seong, Y.Dondelinger, J.Shin, M.Jeong, H.K.Lee, J.H.Kim, S.Y.Han, et al. CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3. Nat Cell Biol 2016; 18:291-302; PMID:26900751; http://dx.doi.org/10.1038/ncb3314
82. N.Takahashi, L.Duprez, S.Grootjans, A.Cauwels, W.Nerinckx, J.B.DuHadaway, V.Goossens, R.Roelandt, F.Van Hauwermeiren, C.Libert, et al. Necrostatin-1 analogues:critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012; 3:e437; PMID:23190609; http://dx.doi.org/10.1038/cddis.2012.176
83. A.Degterev, J.Hitomi, M.Germscheid, I.L.Ch'en, O.Korkina, X.Teng, D.Abbott, G.D.Cuny, C.Yuan, G.Wagner, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4:313-21; PMID:18408713; http://dx.doi.org/10.1038/nchembio.83
84. L.Wang, F.Du, X.Wang. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008; 133:693-703; PMID:18485876; http://dx.doi.org/10.1016/j.cell.2008.03.036
85. J.Wu, Z.Huang, J.Ren, Z.Zhang, P.He, Y.Li, J.Ma, W.Chen, Y.Zhang, X.Zhou, et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 2013; 23:994-1006; PMID:23835476; http://dx.doi.org/10.1038/cr.2013.91
86. L.Sun, H.Wang, Z.Wang, S.He, S.Chen, D.Liao, L.Wang, J.Yan, W.Liu, X.Lei, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148:213-27; PMID:22265413; http://dx.doi.org/10.1016/j.cell.2011.11.031
87. Y.Dondelinger, W.Declercq, S.Montessuit, R.Roelandt, A.Goncalves, I.Bruggeman, P.Hulpiau, K.Weber, C.A.Sehon, R.W.Marquis, et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014; 7:971-81; PMID:24813885; http://dx.doi.org/10.1016/j.celrep.2014.04.026
88. H.Wang, L.Sun, L.Su, J.Rizo, L.Liu, L.F.Wang, F.S.Wang, X.Wang. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014; 54:133-46; PMID:24703947; http://dx.doi.org/10.1016/j.molcel.2014.03.003
89. X.Chen, W.Li, J.Ren, D.Huang, W.T.He, Y.Song, C.Yang, W.Li, X.Zheng, P.Chen, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 2014; 24:105-21; PMID:24366341; http://dx.doi.org/10.1038/cr.2013.171
90. Q.Remijsen, V.Goossens, S.Grootjans, C.Van den Haute, N.Vanlangenakker, Y.Dondelinger, R.Roelandt, I.Bruggeman, A.Goncalves, M.J.Bertrand, et al. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis 2014; 5:e1004; PMID:24434512; http://dx.doi.org/10.1038/cddis.2013.531
91. S.W.Tait, A.Oberst, G.Quarato, S.Milasta, M.Haller, R.Wang, M.Karvela, G.Ichim, N.Yatim, M.L.Albert, et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep 2013; 5:878-85; PMID:24268776; http://dx.doi.org/10.1016/j.celrep.2013.10.034
92. Z.Wang, H.Jiang, S.Chen, F.Du, X.Wang. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012; 148:228-43; PMID:22265414; http://dx.doi.org/10.1016/j.cell.2011.11.030
93. K.Moriwaki, N.Farias Luz, S.Balaji, M.J.De Rosa, C.L.O'Donnell, P.J.Gough, J.Bertin, R.M.Welsh, F.K.Chan. The Mitochondrial Phosphatase PGAM5 Is Dispensable for Necroptosis but Promotes Inflammasome Activation in Macrophages. J Immunol 2016; 196:407-15; PMID:2682950; http://dx.doi.org/10.4049/jimmunol.1501662
94. J.Karch, J.Q.Kwong, A.R.Burr, M.A.Sargent, J.W.Elrod, P.M.Peixoto, S.Martinez-Caballero, H.Osinska, E.H.Cheng, J.Robbins, et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. eLife 2013; 2:e00772; PMID:23991283; http://dx.doi.org/10.7554/eLife.00772
95. K.M.Irrinki, K.Mallilankaraman, R.J.Thapa, H.C.Chandramoorthy, F.J.Smith, N.R.Jog, R.K.Gandhirajan, S.G.Kelsen, S.R.Houser, M.J.May, et al. Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis. Mol Cell Biol 2011; 31:3745-58; PMID:21746883; http://dx.doi.org/10.1128/MCB.05303-11
96. O.Canli, Y.B.Alankus, S.Grootjans, N.Vegi, L.Hultner, P.S.Hoppe, T.Schroeder, P.Vandenabeele, G.W.Bornkamm, F.R.Greten. Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 2016; 127:139-48; PMID:26463424; http://dx.doi.org/10.1182/blood-2015-06-654194
97. B.Schenk, S.Fulda. Reactive oxygen species regulate Smac mimetic/TNFalpha-induced necroptotic signaling and cell death. Oncogene 2015 34(47):5796-806; http:dx.doi.org/10.1038/onc.2015.35
98. W.Wu, P.Liu, J.Li. Necroptosis:an emerging form of programmed cell death. Crit Rev Oncol Hematol 2012; 82:249-58; PMID:21962882; http://dx.doi.org/10.1016/j.critrevonc.2011.08.004
99. Q.Zhang, M.Raoof, Y.Chen, Y.Sumi, T.Sursal, W.Junger, K.Brohi, K.Itagaki, C.J.Hauser. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-7; PMID:20203610; http://dx.doi.org/10.1038/nature08780
100. M.Sade-Feldman, J.Kanterman, E.Ish-Shalom, M.Elnekave, E.Horwitz, M.Baniyash. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013; 38:541-54; PMID:23477736; http://dx.doi.org/10.1016/j.immuni.2013.02.007
101. H.S.Choi, J.W.Kang, S.M.Lee. Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. Translat Res 2015; 166(3):292-303; PMID:25936762; http://dx.doi.org/10.1016/j.trsl.2015.04.002
102. L.M.Coussens, Z.Werb. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
103. B.Hoesel, J.A.Schmid. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 2013; 12:86; PMID:23915189; http://dx.doi.org/10.1186/1476-4598-12-86
104. C.Holohan, S.Van Schaeybroeck, D.B.Longley, P.G.Johnston. Cancer drug resistance:an evolving paradigm. Nat Rev Cancer 2013; 13:714-26; PMID:24060863; http://dx.doi.org/10.1038/nrc3599
105. W.Han, L.Li, S.Qiu, Q.Lu, Q.Pan, Y.Gu, J.Luo, X.Hu. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007; 6:1641-9; PMID:17513612; http://dx.doi.org/10.1158/1535-7163.MCT-06-0511
106. X.Chen, L.Yang, N.Zhang, J.A.Turpin, R.W.Buckheit, C.Osterling, J.J.Oppenheim, O.M.Howard. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrobial agents and chemotherapy 2003; 47:2810-6; PMID:12936978; http://dx.doi.org/10.1128/AAC.47.9.2810-2816.2003
107. D.Liang, Y.Sun, Y.Shen, F.Li, X.Song, E.Zhou, F.Zhao, Z.Liu, Y.Fu, M.Guo, et al. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway. Int Immunopharmacol 2013; 16:475-80; PMID:23651796; http://dx.doi.org/10.1016/j.intimp.2013.04.020
108. Z.Fu, B.Deng, Y.Liao, L.Shan, F.Yin, Z.Wang, H.Zeng, D.Zuo, Y.Hua, Z.Cai. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer 2013; 13:580; PMID:24314238; http://dx.doi.org/10.1186/1471-2407-13-580
109. N.Wada, Y.Kawano, S.Fujiwara, Y.Kikukawa, Y.Okuno, M.Tasaki, M.Ueda, Y.Ando, K.Yoshinaga, M.Ri, et al. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. Int J Oncol 2015; 46:963-72; PMID:25530098; http://dx.doi.org/10.3892/ijo.2014.2804
110. L.Galluzzi, L.Senovilla, I.Vitale, J.Michels, I.Martins, O.Kepp, M.Castedo, G.Kroemer. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869-83; PMID:21892204; http://dx.doi.org/10.1038/onc.2011.384
111. K.E.McCabe, K.Bacos, D.Lu, J.R.Delaney, J.Axelrod, M.D.Potter, M.Vamos, V.Wong, N.D.Cosford, R.Xiang, et al. Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. Cell Death Dis 2014; 5:e1496; PMID:25356865; http://dx.doi.org/10.1038/cddis.2014.448
112. J.R.Cerhan, S.M.Ansell, Z.S.Fredericksen, N.E.Kay, M.Liebow, T.G.Call, A.Dogan, J.M.Cunningham, A.H.Wang, W.Liu-Mares, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110:4455-63; PMID:17827388; http://dx.doi.org/10.1182/blood-2007-05-088682
113. P.Liu, B.Xu, W.Shen, H.Zhu, W.Wu, Y.Fu, H.Chen, H.Dong, Y.Zhu, K.Miao, et al. Dysregulation of TNFalpha-induced necroptotic signaling in chronic lymphocytic leukemia:suppression of CYLD gene by LEF1. Leukemia 2012; 26:1293-300; PMID:22157808; http://dx.doi.org/10.1038/leu.2011.357
114. C.English, J.J.Aloi. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis. Clin Ther 2015; 37:691-715; PMID:25846320; http://dx.doi.org/10.1016/j.clinthera.2015.03.001
115. S.A.Saddoughi, S.Gencer, Y.K.Peterson, K.E.Ward, A.Mukhopadhyay, J.Oaks, J.Bielawski, Z.M.Szulc, R.J.Thomas, S.P.Selvam, et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med 2013; 5:105-21; PMID:23180565; http://dx.doi.org/10.1002/emmm.201201283
116. L.Zhang, H.Wang, K.Ding, J.Xu. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicology letters 2015; 236:43-59; PMID:25939952; http://dx.doi.org/10.1016/j.toxlet.2015.04.015
117. T.L.Aaes, A.Kaczmarek, T.Delvaeye, B.De Craene, S.De Koker, L.Heyndrickx, I.Delrue, J.Taminau, B.Wiernicki, P.De Groote, et al. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep 2016; 15:274-87; PMID:27050509; http://dx.doi.org/10.1016/j.celrep.2016.03.037
118. H.Ye, X.Liu, M.Lv, Y.Wu, S.Kuang, J.Gong, P.Yuan, Z.Zhong, Q.Li, H.Jia, et al. MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia. Nucleic Acids Res 2012; 40:5201-14; PMID:22362744; http://dx.doi.org/10.1093/nar/gks175
119. D.Iliopoulos, S.A.Jaeger, H.A.Hirsch, M.L.Bulyk, K.Struhl. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493-506; PMID:20797623; http://dx.doi.org/10.1016/j.molcel.2010.07.023
120. Z.Su, Z.Yang, Y.Xu, Y.Chen, Q.Yu. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget 2015; 6:8474-90; PMID:25893379; http://dx.doi.org/10.18632/oncotarget.3523